• slidebg1
Investing in disruption, one company at a time

Irving Investors is a growth fund with a sector agnostic approach.
We employ a single name strategy to maximize alpha across the capital structure.


Jeremy Abelson

Jeremy founded Irving Investors in 2009 after two successful exits in the tech space. He runs Irving as a crossover fund with a predominantly long-only public equities strategy and an active late-stage venture portfolio. Jeremy combines his experience as an entrepreneur with institutional investing to find both disruptive and durable long-term opportunities. With an operating business background, Jeremy employs a single name strategy across asset classes and applies a venture approach to public market investing.

Jeremy seeks to build meaningful company relationships. He looks at his investments as being supportive capital and has taken board seats with two of Irving’s portfolio companies.

Jeremy is actively involved in a number of philanthropic organizations. He is a founder and board member of the Cherry Hills Police Department Foundation, he serves on the Junior Board (2221 Society) of Children’s Hospital Colorado, he sits on the board of the Blue Sky Fund, he is on the AIR Society at National Jewish Health and is actively involved with AIPAC.

Jeremy is originally from San Mateo, CA and graduated from The University of Michigan.

Portfolio Manager / Head of Credit
Chris joined Irving Investors in July of 2014 and holds the title of Portfolio Manager and Head of Credit. Chris started his career managing Corporate Loan portfolios at Lehman Brothers and Morgan Stanley. Most recently, before joining Irving he managed a Credit focused Macro portfolio at Millennium Partners in New York. In addition to his focus on Credit, Chris is actively building Irving’s relationships and investments in the Private space. Chris is originally from Seattle, WA and graduated from Washington University in St. Louis with a BSBA in Finance, Accounting, and International Business, as well as a MSBA in Accounting.
Portfolio Manager / Crossover Fund
Jacob joined Irving in 2021 as a Portfolio Manager with a focus on technology and generalist investing. Jacob helps run a crossover strategy focusing on both public and private companies. Jacob began his career in 2010 working for Merrill Lynch on both their Software and Internet Equity Research teams. In 2013 he joined Unicom Capital LLC and worked in their New York and Denver offices. He served as Vice President of Equity Research there where he focused on technology as well as some generalist work. Jacob is a graduate with High Honors from the Haas Business School at the University of California Berkeley.
Andrew Kalmar
Andrew Kalmar
Portfolio Manager / Life Sciences
Andrew joined Irving in 2019 as a Portfolio Manager with a dedicated Healthcare focus. Andrew runs a crossover strategy focusing on both public and private companies. Andrew began his career in 2002 working for the Lord Abbett Bond Debenture fund, which today remains one of the largest high-yield funds in existence. In 2004 he moved to Denver as a co-founder of Independence Capital Asset Partners, a growth focused hedge fund where he managed the healthcare portfolio. In 2015 he was a co-founder of Roubaix Capital which was a spin out of ICAP and he left in 2018. Andrew also actively consults with drug development companies as well as other investors.
Head Trader
Travis joined Irving in 2021 as a Trader focused on equities and derivatives. Travis manages Irving’s growth and event driven strategy. Additionally, he supports the Crossover Fund and additional generalist investing strategies for the firm. Prior to Irving, Travis spent three years at Unicom Capital as an Equity Trader and Associate. At Unicom, he focused primarily on execution trading for the long-only strategy. Travis is originally from Colorado and graduated from the Leeds School of Business at the University of Colorado, Boulder with a B.S. in Finance.
Mason Yeager
Mason Yeager
Mason joined Irving in 2021 as an analyst focused on Irving’s Crossover Fund. He manages the investment processes for the technology and healthcare crossover strategy. He also oversees Irving’s deal sourcing and company relationship building efforts. Mason is originally from Ocean City, NJ and graduated with a B.A. in Economics from the University of Colorado, Boulder.


Irving was founded in 2009 as a dedicated equity fund focused on disruptive technology and high growth opportunities, and has since expanded into Credit and Private investments.

The fund looks to form meaningful relationships with companies by offering its capital, expertise, and connections to promote growth and return on investment.

Irving has been involved in several successful private exits and is a trusted advisor and LP in Venture Capital funds.

The firm has offices in New York and Colorado.


Our Approach


205 Detroit St, Ste 400
Denver, CO